Literature DB >> 17051641

Identification of putative in vivo substrates of calpain 3 by comparative proteomics of overexpressing transgenic and nontransgenic mice.

Niaz Cohen1, Elena Kudryashova, Irina Kramerova, Louise V B Anderson, Jacques S Beckmann, Katherine Bushby, Melissa J Spencer.   

Abstract

Calpain 3 (CAPN3) is a calcium-dependent protease, mutations in which cause limb girdle muscular dystrophy type 2A. To explore the physiological function of CAPN3, we compared the proteomes of transgenic mice that overexpress CAPN3 (CAPN3 Tg) and their nontransgenic (non-Tg) counterparts. We first examined known muscular dystrophy-related proteins to determine if overexpression of CAPN3 results in a change in their distribution or concentration. This analysis did not identify any known muscular dystrophy proteins as substrates of CAPN3. Next, we used a proteomic approach to compare and identify differentially represented proteins in 2-DE of CAPN3 Tg and non-Tg mice. LC-MS/MS analysis led to the identification of ten possible substrates for CAPN3, classified into two major functional categories: metabolic and myofibrillar. Myosin light chain 1 (MLC1) was focused upon because our previous studies suggested a role for CAPN3 in sarcomere remodeling. In this study, CAPN3 was shown to proteolyze MLC1 in vitro. These studies are the first to identify possible substrates for CAPN3 in an in vivo system and support a role for CAPN3 in sarcomere remodeling by cleavage of myofibrillar proteins such as MLC1. In addition, these data also suggest a role for CAPN3 in mitochondrial protein turnover.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17051641     DOI: 10.1002/pmic.200600199

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  17 in total

1.  Calpain3 is expressed in a proteolitically active form in papillomavirus-associated urothelial tumors of the urinary bladder in cattle.

Authors:  Sante Roperto; Roberta De Tullio; Cinzia Raso; Roberto Stifanese; Valeria Russo; Marco Gaspari; Giuseppe Borzacchiello; Monica Averna; Orlando Paciello; Gianni Cuda; Franco Roperto
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

2.  Mitochondrial abnormalities, energy deficit and oxidative stress are features of calpain 3 deficiency in skeletal muscle.

Authors:  Irina Kramerova; Elena Kudryashova; Benjamin Wu; Sean Germain; Krista Vandenborne; Nadine Romain; Ronald G Haller; M Anthony Verity; Melissa J Spencer
Journal:  Hum Mol Genet       Date:  2009-05-29       Impact factor: 6.150

Review 3.  Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance.

Authors:  Jacques S Beckmann; Melissa Spencer
Journal:  Neuromuscul Disord       Date:  2008-10-29       Impact factor: 4.296

4.  Insertion sequence 1 from calpain-3 is functional in calpain-2 as an internal propeptide.

Authors:  Christian-Scott E McCartney; Qilu Ye; Robert L Campbell; Peter L Davies
Journal:  J Biol Chem       Date:  2018-09-25       Impact factor: 5.157

5.  Comprehensive survey of p94/calpain 3 substrates by comparative proteomics--possible regulation of protein synthesis by p94.

Authors:  Yasuko Ono; Chikako Hayashi; Naoko Doi; Fujiko Kitamura; Mayumi Shindo; Kenichi Kudo; Takuichi Tsubata; Mitsuaki Yanagida; Hiroyuki Sorimachi
Journal:  Biotechnol J       Date:  2007-05       Impact factor: 4.677

6.  Calpain 3 is a rapid-action, unidirectional proteolytic switch central to muscle remodeling.

Authors:  Antoine de Morrée; David Lutje Hulsik; Antonietta Impagliazzo; Herman H H B M van Haagen; Paula de Galan; Alexandra van Remoortere; Peter A C 't Hoen; Gertjan B van Ommen; Rune R Frants; Silvère M van der Maarel
Journal:  PLoS One       Date:  2010-08-04       Impact factor: 3.240

7.  Calpain 3 is important for muscle regeneration: evidence from patients with limb girdle muscular dystrophies.

Authors:  Simon Hauerslev; Marie-Louise Sveen; Morten Duno; Corrado Angelini; John Vissing; Thomas O Krag
Journal:  BMC Musculoskelet Disord       Date:  2012-03-23       Impact factor: 2.362

8.  Novel protein-protein interactions inferred from literature context.

Authors:  Herman H H B M van Haagen; Peter A C 't Hoen; Alessandro Botelho Bovo; Antoine de Morrée; Erik M van Mulligen; Christine Chichester; Jan A Kors; Johan T den Dunnen; Gert-Jan B van Ommen; Silvère M van der Maarel; Vinícius Medina Kern; Barend Mons; Martijn J Schuemie
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

Review 9.  Molecular and cellular basis of genetically inherited skeletal muscle disorders.

Authors:  James J Dowling; Conrad C Weihl; Melissa J Spencer
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07-13       Impact factor: 94.444

10.  Gene expression profiling in limb-girdle muscular dystrophy 2A.

Authors:  Amets Sáenz; Margarita Azpitarte; Rubén Armañanzas; France Leturcq; Ainhoa Alzualde; Iñaki Inza; Federico García-Bragado; Gaspar De la Herran; Julián Corcuera; Ana Cabello; Carmen Navarro; Carolina De la Torre; Eduard Gallardo; Isabel Illa; Adolfo López de Munain
Journal:  PLoS One       Date:  2008-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.